Effect of WOW process parameters on morphology and burst release of FITC-dextran loaded PLGA microspheres.
about
Bioerodable PLGA-Based Microparticles for Producing Sustained-Release Drug Formulations and Strategies for Improving Drug LoadingFe3O4-based PLGA nanoparticles as MR contrast agents for the detection of thrombosis.Influence of morphology and drug distribution on the release process of FITC-dextran-loaded microspheres prepared with different types of PLGA.Microencapsulation of cytarabine using poly(ethylene glycol)-poly(epsilon-caprolactone) diblock copolymers as surfactant agents.Polymeric nanocarriers for transport modulation across the pulmonary epithelium: dendrimers, polymeric nanoparticles, and their nanoblendsPorous silicon oxide-PLGA composite microspheres for sustained ocular delivery of daunorubicinβ-methasone-containing biodegradable poly(lactide-co-glycolide) acid microspheres for intraarticular injection: effect of formulation parameters on characteristics and in vitro release.Microparticles prepared from sulfenamide-based polymers.Multifunctional polymeric nanoparticles doubly loaded with SPION and ceftiofur retain their physical and biological properties.Three-dimensional study of poly(lactic co-glycolic acid) micro-porous microspheres using hard X-ray nano-tomography.Extended and sequential delivery of protein from injectable thermoresponsive hydrogelsDetermination of the Porosity of PLGA Microparticles by Tracking Their Sedimentation Velocity Using a Flow Imaging Microscope (FlowCAM).Controlled delivery of tauroursodeoxycholic acid from biodegradable microspheres slows retinal degeneration and vision loss in P23H rats.Biodegradable PLGA-Based Drug Delivery Systems for Modulating Ocular Surface Disease under Experimental Murine Dry EyeDevelopment of a novel bioerodible dexamethasone implant for uveitis and postoperative cataract inflammationThermostabilization of inactivated polio vaccine in PLGA-based microspheres for pulsatile release.Peptide/protein vaccine delivery system based on PLGA particles.Therapeutic strategies based on polymeric microparticles.Revolutionizing drug delivery through biodegradable multilayered particles.Recent advances in polymeric microspheres for parenteral drug delivery--part 1.An overview of preparation and evaluation sustained-release injectable microspheres.PLGA: a unique polymer for drug delivery.Microparticulate based topical delivery system of clobetasol propionate.Next generation vaccines: single-dose encapsulated vaccines for improved global immunisation coverage and efficacy.Protective microencapsulation of β-lapachone using porous glass membrane technique based on experimental optimisation.Improved Poly (D,L-lactide) nanoparticles-based formulation for hair follicle targeting.Retention of insulin-like growth factor I bioactivity during the fabrication of sintered polymeric scaffoldsRelease optimization of epidermal growth factor from PLGA microparticles.Microencapsulation of alpha-mangostin into PLGA microspheres and optimization using response surface methodology intended for pulmonary delivery.Nanotized Curcumin and Miltefosine, a Potential Combination for Treatment of Experimental Visceral Leishmaniasis.Biodegradable Polymeric Microsphere-Based Drug Delivery for Inductive Browning of Fat.Sustained release of calcium hydroxide from poly(DL-lactide-co-glycolide) acid microspheres for apexification.PLGA nanoparticles for peptide receptor radionuclide therapy of neuroendocrine tumors: a novel approach towards reduction of renal radiation dose.Kanamycin Sulphate Loaded PLGA-Vitamin-E-TPGS Long Circulating Nanoparticles Using Combined Coating of PEG and Water-Soluble Chitosan.Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier.Droplet based microfluidic fabrication of designer microparticles for encapsulation applications.Effects of antibiotic physicochemical properties on their release kinetics from biodegradable polymer microparticles.A one-step modified method to reduce the burst initial release from PLGA microspheres.Long-acting formulation of a new muscarinic receptor antagonist for the treatment of overactive bladder.Preparation and evaluation of double-walled microparticles prepared with a modified water-in-oil-in-oil-in-water (w1/o/o/w3) method.
P2860
Q26738335-8CAD921D-1E5C-43C0-AB79-917A9B532598Q30362955-CC42787E-D863-4CC2-A1DD-20965CEF5491Q33362424-DE89B2DB-D2B2-4D29-A4BE-CFD7A542FBABQ33514058-EC2C0824-05A0-4A99-905F-DC91C107AB90Q33574188-26288A66-83F7-41C3-8BA0-20677B6117DCQ33932883-F09461CE-1346-4DD7-8EE3-EC5CB7FC805FQ34147976-ECD713D1-64C4-42D5-9E25-EE07F8D62168Q34829176-B388FB28-374D-4A8B-ABD4-36F8E77F1FC6Q35102454-B253A0B8-A4E9-4D0C-B944-1A4E9B48419CQ35236195-E345D7EF-5087-46A0-B8A6-2E17597567FEQ35696724-489D3E95-EE8D-411C-A174-6C4CD537B636Q36284684-2990FAA8-22DB-4BFA-AEEC-037CF4C17458Q36380667-F85C1AE6-3137-4364-B1B1-1B9BF956DB31Q36734622-033A759B-187E-48BB-9CEA-E1AE52789439Q37017458-8B90D686-4806-4A5E-B481-AC003B40EDA9Q37048185-DA8B209B-1831-4675-B347-6A65585ECE30Q37838652-FFC49F55-89DE-46C5-8AE5-044EF84E418DQ38016146-01638868-85DE-452B-8DB2-AB0742220FF1Q38022059-4AAB09A0-97A9-4C69-BC0A-8837DF1A554FQ38029806-890EC764-38AD-4369-A27A-FEEEAEF712DBQ38058839-90D3CC62-1589-42DE-A6B4-489ECE1CBE5BQ38309875-127E60E0-A22D-4540-800A-7BDA48D7FCAEQ38312122-2810E76F-21EB-440D-B4AB-931BF00CFE19Q38341522-73B2CF3A-47CD-4B7B-A559-84142B854CCDQ38400036-0443D633-92F8-460E-9997-9BCF6D769E8FQ38922491-934C1233-165B-4B37-82D5-51815409848CQ39021252-E9D33C94-CB0F-4772-B52D-63BE571F5A73Q39138010-75425D5F-C6A0-48F9-A253-B64180372C87Q39158268-27934BEF-D8E7-4598-8AD7-9803E44722E6Q39526125-329A37DF-CAE4-40B5-9250-9CB740FB0FE4Q40263189-2EC34695-887B-4962-80FC-D6E9FCA25AB8Q40736308-D621F61C-FAAE-44B3-B287-4B43D296EF0CQ41787392-E55CEA02-BB8C-4FEA-BE56-382391119EF2Q41822512-FD471B4E-C163-4EE5-BCEC-20773F641BEDQ42153590-DDC286F6-10E3-4A43-85BA-36652154E1DAQ42261248-F254F931-FFC1-4E59-8970-6148961E96EFQ42549724-FFAAED0F-11C4-4EF2-B248-C50D88B94B12Q43196487-ADFB849B-2237-4C89-968E-BC02B02BE5D6Q44023036-8D766FCF-7345-4534-9992-14C801C7425AQ45377241-691C88E6-1B6F-4C76-8E07-87C6723D5C31
P2860
Effect of WOW process parameters on morphology and burst release of FITC-dextran loaded PLGA microspheres.
description
2006 nî lūn-bûn
@nan
2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Effect of WOW process paramete ...... tran loaded PLGA microspheres.
@ast
Effect of WOW process paramete ...... tran loaded PLGA microspheres.
@en
Effect of WOW process paramete ...... tran loaded PLGA microspheres.
@nl
type
label
Effect of WOW process paramete ...... tran loaded PLGA microspheres.
@ast
Effect of WOW process paramete ...... tran loaded PLGA microspheres.
@en
Effect of WOW process paramete ...... tran loaded PLGA microspheres.
@nl
prefLabel
Effect of WOW process paramete ...... tran loaded PLGA microspheres.
@ast
Effect of WOW process paramete ...... tran loaded PLGA microspheres.
@en
Effect of WOW process paramete ...... tran loaded PLGA microspheres.
@nl
P2093
P1476
Effect of WOW process paramete ...... tran loaded PLGA microspheres.
@en
P2093
Andreas Schaper
Cuifang Cai
Shirui Mao
P304
P356
10.1016/J.IJPHARM.2006.10.036
P407
P577
2006-10-28T00:00:00Z